Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Lyra Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
LYRA
Nasdaq
8731
https://lyratherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Lyra Therapeutics Inc
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
- Mar 28th, 2024 11:08 am
Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well
- Mar 26th, 2024 11:27 am
Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
- Mar 25th, 2024 12:50 pm
Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
- Mar 23rd, 2024 9:31 am
Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?
- Mar 22nd, 2024 1:55 pm
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Mar 21st, 2024 8:01 pm
Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going
- Mar 8th, 2024 1:50 pm
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 1st, 2024 9:01 pm
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
- Mar 1st, 2024 2:45 pm
5 Small Drug Stocks to Buy From a Rebounding Industry
- Feb 29th, 2024 1:53 pm
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?
- Feb 26th, 2024 8:58 am
Here's What Could Help Lyra Therapeutics, Inc. (LYRA) Maintain Its Recent Price Strength
- Feb 21st, 2024 1:50 pm
Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
- Feb 7th, 2024 11:30 am
What Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'
- Jan 17th, 2024 1:50 pm
4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
- Dec 20th, 2023 1:45 pm
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical
- Dec 12th, 2023 2:02 pm
5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year
- Dec 11th, 2023 3:37 pm
Lyra Therapeutics Insider Ups Holding By 11% During Year
- Nov 15th, 2023 10:04 am
Executive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More Shares
- Nov 15th, 2023 10:01 am
Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 7th, 2023 9:01 pm
Scroll